All Names:

A4, ABPP, AD1, APP, APPI, Alzheimer's disease amyloid protein, Amyloid beta A4 protein precursor, Beta-amyloid protein 40, Beta-amyloid protein 42, C31, C83, CVAP, Cerebral vascular amyloid peptide, Gamma-CTF(50), Gamma-CTF(57), Gamma-CTF(59), P3(40), P3(42), PN-II, PreA4, Protease nexin-II, Soluble APP-alpha (S-APP- alpha), Soluble APP-beta (S-APP-beta)

All Sites:

Human: Thr743; Mouse: Thr743; Rat: Thr743

Form of Antibody:

Rabbit IgG in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Storage/Stability:

Store at -20℃/1 year

Immunogen:

The antiserum was produced against synthesized phosphopeptide derived from humanAmyloid βA4 around the phosphorylation site of threonine 743 (A-V-T^P-P-E).

Purification:

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.

Specificity/Sensitivity:

Amyloid βA4 (phospho-Thr743/668) antibodydetects endogenous levels ofAmyloid βA4 only when phosphorylated at threonine 743.

Reactivity:

Human, Mouse, Rat

Applications:

WB: 1:500~1:3000      IHC: 1:50~1:100   

IF: 1:100~1:500      ELISA: 1:10000